These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8959764)

  • 1. Sleep and signs of attention during 3 months of intranasal vasopressin: a pilot study in two elderly subjects.
    Perras B; Mölle M; Born J; Fehm HL
    Peptides; 1996; 17(7):1253-5. PubMed ID: 8959764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial treatment of age-related sleep disturbances with prolonged intranasal vasopressin.
    Perras B; Pannenborg H; Marshall L; Pietrowsky R; Born J; Lorenz Fehm H
    J Clin Psychopharmacol; 1999 Feb; 19(1):28-36. PubMed ID: 9934940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of sleep and pituitary-adrenal inhibition after subchronic intranasal vasopressin treatment in elderly humans.
    Perras B; Wagner U; Born J; Fehm HL
    J Clin Psychopharmacol; 2003 Feb; 23(1):35-44. PubMed ID: 12544374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-trial administration of vasopressin in humans does not enhance memory formation (vasopressin and memory consolidation).
    Gais S; Sommer M; Fischer S; Perras B; Born J
    Peptides; 2002 Mar; 23(3):581-3. PubMed ID: 11836010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychological effects of vasopressin in healthy humans.
    Born J; Pietrowsky R; Fehm HL
    Prog Brain Res; 1998; 119():619-43. PubMed ID: 10074814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verbal memory after three months of intranasal vasopressin in healthy old humans.
    Perras B; Droste C; Born J; Fehm HL; Pietrowsky R
    Psychoneuroendocrinology; 1997 Aug; 22(6):387-96. PubMed ID: 9364618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain potentials and attention after acute and subchronic intranasal administration ofACTH 4-10 and desacetyl-alpha-MSH in humans.
    Smolnik R; Mölle M; Fehm HL; Born J
    Neuroendocrinology; 1999 Jul; 70(1):63-72. PubMed ID: 10420094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of repeated gaboxadol administration on night sleep and next-day performance in healthy elderly subjects.
    Mathias S; Zihl J; Steiger A; Lancel M
    Neuropsychopharmacology; 2005 Apr; 30(4):833-41. PubMed ID: 15602499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longtime administration of growth hormone-releasing hormone (GHRH) does not restore the reduced efficiency of GHRH on sleep endocrine activity in 2 old-aged subjects--a preliminary study.
    Murck H; Frieboes RM; Schier T; Steiger A
    Pharmacopsychiatry; 1997 Jul; 30(4):122-4. PubMed ID: 9271777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain potential changes after intranasal vs. intravenous administration of vasopressin: evidence for a direct nose-brain pathway for peptide effects in humans.
    Pietrowsky R; Strüben C; Mölle M; Fehm HL; Born J
    Biol Psychiatry; 1996 Mar; 39(5):332-40. PubMed ID: 8704064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal insulin decreases circulating cortisol concentrations during early sleep in elderly humans.
    Thienel M; Wilhelm I; Benedict C; Born J; Hallschmid M
    Neurobiol Aging; 2017 Jun; 54():170-174. PubMed ID: 28385552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemosensory event-related potentials during sleep--a pilot study.
    Stuck BA; Weitz H; Hörmann K; Maurer JT; Hummel T
    Neurosci Lett; 2006 Oct; 406(3):222-6. PubMed ID: 16934401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of enhanced cerebrospinal fluid levels of vasopressin, vasopressin antagonist or vasoactive intestinal polypeptide on circadian sleep-wake rhythm in the rat.
    Kruisbrink J; Mirmiran M; Van der Woude TP; Boer GJ
    Brain Res; 1987 Sep; 419(1-2):76-86. PubMed ID: 3676743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral Mg(2+) supplementation reverses age-related neuroendocrine and sleep EEG changes in humans.
    Held K; Antonijevic IA; Künzel H; Uhr M; Wetter TC; Golly IC; Steiger A; Murck H
    Pharmacopsychiatry; 2002 Jul; 35(4):135-43. PubMed ID: 12163983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspects of sleep, daytime vigilance, mental performance and psychotropic drug treatment in the elderly.
    Spiegel R
    Gerontology; 1982; 28 Suppl 1():68-82. PubMed ID: 7044904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasopressin acts in the subfornical organ to decrease blood pressure.
    Smith PM; Ferguson AV
    Neuroendocrinology; 1997 Aug; 66(2):130-5. PubMed ID: 9263210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DDAVP in treatment of vasopressin-sensitive diabetes insipidus.
    Ward MK; Fraser TR
    Br Med J; 1974 Jul; 3(5923):86-9. PubMed ID: 4851464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal insulin improves cognition and modulates beta-amyloid in early AD.
    Reger MA; Watson GS; Green PS; Wilkinson CW; Baker LD; Cholerton B; Fishel MA; Plymate SR; Breitner JC; DeGroodt W; Mehta P; Craft S
    Neurology; 2008 Feb; 70(6):440-8. PubMed ID: 17942819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving sleep and cognition by hypnotic suggestion in the elderly.
    Cordi MJ; Hirsiger S; Mérillat S; Rasch B
    Neuropsychologia; 2015 Mar; 69():176-82. PubMed ID: 25660206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The superior sleep of healthy elderly nuns.
    Hoch CC; Reynolds CF; Kupfer DJ; Houck PR; Berman SR; Stack JA
    Int J Aging Hum Dev; 1987; 25(1):1-9. PubMed ID: 3429036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.